CL
PDLI

CSS LLC’s PDL BioPharma, Inc. PDLI Stock Holding History

CSS LLC’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13,600
Closed -$29K – 818
2016
Q4 		$29K Buy
+13,600
New +$37.9K ﹤0.01% 663
2016
Q2 		– Sell
-10,000
Closed -$33K – 816
2016
Q1 		$33K Hold
10,000
– – ﹤0.01% 641
2015
Q4 		$35K Buy
+10,000
New +$41.9K ﹤0.01% 660

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CSS LLC's PDLI Position: Q1 2017 in Review

CSS LLC sold out of PDL BioPharma, Inc. (PDLI) in Q1 2017, closing a stake of 8,068 shares — an estimated $17K sold.

CSS LLC first reported a position in PDLI in Q1 2014 and held it in 3 quarters. The position peaked at $127K in Q2 2014. 174 funds tracked by Wall St. Rank hold PDLI as of Q1 2017.

  • CSS LLC reported no remaining PDL BioPharma, Inc. position as of Q1 2017 after selling out during the quarter.
  • CSS LLC sold 8,068 PDL BioPharma, Inc. shares in Q1 2017, an estimated $17K.
  • CSS LLC first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 3 quarters.
  • CSS LLC's PDL BioPharma, Inc. position peaked at $127K in Q2 2014.
  • 174 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2017.

Based on CSS LLC's 13F filing for Q1 2017, filed 15 May 2017.